A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes

NCT04378920 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

COVID19, Sepsis or Other Causes
Acute Respiratory Distress Syndrome

Interventions

DRUG: LEAF-4L6715

Sponsor

Institut de cancérologie Strasbourg Europe

Collaborators

[object Object]